{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:42:07Z","timestamp":1793234527923,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T00:00:00Z","timestamp":1381968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00192-013-2228-2","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T11:36:43Z","timestamp":1381923403000},"page":"601-605","source":"Crossref","is-referenced-by-count":11,"title":["Repeated botulinum toxin type A (Dysport\u00ae) injections for women with intractable detrusor overactivity: a prospective outcome study"],"prefix":"10.1007","volume":"25","author":[{"given":"Lanka","family":"Abeywickrama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angamuthu","family":"Arunkalaivanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,17]]},"reference":[{"key":"2228_CR1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1024\/0040-5930.57.11.690","volume":"57","author":"B Schurch","year":"2000","unstructured":"Schurch B (2000) Bladder dysfunction after spinal and peripheral nerve lesions. Ther Umsch 57:690\u2013697","journal-title":"Ther Umsch"},{"key":"2228_CR2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","volume":"342","author":"B Schurch","year":"2000","unstructured":"Schurch B, Schmid DM, St\u00f6hrer M (2000) Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342:665","journal-title":"N Engl J Med"},{"key":"2228_CR3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:644\u2013650","journal-title":"Eur Urol"},{"key":"2228_CR4","doi-asserted-by":"crossref","unstructured":"Patel AK, Patterson JM, Chapple CR (2006) The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity. Int J Clin Pract Suppl 151:27\u201332","DOI":"10.1111\/j.1742-1241.2006.01212.x"},{"key":"2228_CR5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1464-410X.2012.11282.x","volume":"111","author":"A Mohee","year":"2013","unstructured":"Mohee A, Khan A, Harris N, Eardley I (2013) Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int 111:106\u2013113","journal-title":"BJU Int"},{"key":"2228_CR6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2011.12.011","volume":"61","author":"C Dowson","year":"2012","unstructured":"Dowson C, Watkins J, Khan MS, Dasgupta P, Sahai A (2012) Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates. Eur Urol 61:834\u2013839","journal-title":"Eur Urol"},{"key":"2228_CR7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrurol.2010.187","volume":"7","author":"C Dowson","year":"2010","unstructured":"Dowson C, Khan MS, Dasgupta P, Sahai A (2010) Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity. Nat Rev Urol 7:661\u2013667","journal-title":"Nat Rev Urol"},{"key":"2228_CR8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.urology.2009.05.097","volume":"75","author":"A Sahai","year":"2010","unstructured":"Sahai A, Dowson C, Khan MS, Dasgupta P, GKT Botulinum Study Group (2010) Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity. Urology 75:552\u2013558","journal-title":"Urology"},{"key":"2228_CR9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.juro.2010.12.002","volume":"185","author":"S Khan","year":"2011","unstructured":"Khan S, Game X, Kalsi V, Gonzales G, Panicker J, Elneil S, Apostolidis A, Hamid R, Dasgupta P, Kessler TM, Fowler CJ (2011) Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis. J Urol 185:1344\u20131349","journal-title":"J Urol"},{"key":"2228_CR10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00404-012-2349-8","volume":"286","author":"R Granese","year":"2012","unstructured":"Granese R, Adile G, Gugliotta G, Cucinella G, Saitta S, Adile B (2012) Botox(\u00ae) for idiopathic overactive bladder: efficacy, duration and safety. Effectiveness of subsequent injection. Arch Gynecol Obstet 286:923\u2013929","journal-title":"Arch Gynecol Obstet"},{"key":"2228_CR11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","volume":"50","author":"AK Patel","year":"2006","unstructured":"Patel AK, Patterson JM, Chapple CR (2006) Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results. Eur Urol 50:684\u2013709, discussion 709\u2013710","journal-title":"Eur Urol"},{"key":"2228_CR12","doi-asserted-by":"crossref","unstructured":"Santos-Silva A, da Silva CM, Cruz F (2013) Botulinum toxin treatment for bladder dysfunction. Int J Urol. doi:10.1111\/iju.12188","DOI":"10.1111\/iju.12188"},{"key":"2228_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2710.2007.00835.x","volume":"32","author":"R Wenzel","year":"2007","unstructured":"Wenzel R, Jones D, Borrego JA (2007) Comparing two botulinum toxin type A formulations using manufacturers\u2019 product summaries. J Clin Pharm Ther 32:387\u2013402","journal-title":"J Clin Pharm Ther"},{"key":"2228_CR14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2012.01.051","volume":"61","author":"D Behr-Roussel","year":"2012","unstructured":"Behr-Roussel D, Oger S, Pignol B, Pham E, Le Maux A, Chabrier PE, Caisey S, Compagnie S, Picaut P, Bernab\u00e9 J, Alexandre L, Giuliano F, Denys P (2012) Minimal effective dose of dysport and botox in a rat model of neurogenic detrusor overactivity. Eur Urol 61:1054\u20131061","journal-title":"Eur Urol"},{"key":"2228_CR15","doi-asserted-by":"crossref","unstructured":"Ravindra P, Jackson BL, Parkinson RJ (2013) Botulinum toxin type A for the treatment of non-neurogenic overactive bladder: does using onabotulinumtoxinA (Botox) or abobotulinumtoxinA (Dysport) make a difference? BJU Int 112:94\u201399","DOI":"10.1111\/bju.12028"},{"key":"2228_CR16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1464-410X.2009.08402.x","volume":"103","author":"A Sahai","year":"2009","unstructured":"Sahai A, Dowson C, Khan MS, Dasgupta P (2009) Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial. BJU Int 103:1509\u20131515","journal-title":"BJU Int"},{"key":"2228_CR17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.eururo.2012.02.043","volume":"61","author":"P Dasgupta","year":"2012","unstructured":"Dasgupta P (2012) Volume matters: bladder injections of botulinum toxin type A. Eur Urol 61:1185\u20131186, discussion 1886\u20131887","journal-title":"Eur Urol"},{"key":"2228_CR18","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","volume":"177","author":"A Sahai","year":"2007","unstructured":"Sahai A, Khan MS, Dasgupta P (2007) Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 177:2231\u20132236","journal-title":"J Urol"},{"key":"2228_CR19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1464-410X.2008.07447_3.x","volume":"101","author":"A Sahai","year":"2008","unstructured":"Sahai A, Dowson C, Khan MS, Dasgupta P (2008) Re: efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 101:515\u2013516, author reply 516\u2013517","journal-title":"BJU Int"},{"key":"2228_CR20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1464-410X.2008.08076.x","volume":"103","author":"A Sahai","year":"2009","unstructured":"Sahai A, Sangster P, Kalsi V, Khan MS, Fowler CJ, Dasgupta P (2009) Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable? BJU Int 103:630\u2013634","journal-title":"BJU Int"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-013-2228-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-013-2228-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-013-2228-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T14:51:12Z","timestamp":1558623072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-013-2228-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,17]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1007\/s00192-013-2228-2","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,17]]}}}